Skip to content
MedsAcross

Medicine

Erythromycin 0.5% eye ointment

Erythromycin · Ophthalmic
Available on requestPrescription onlyUS FDAGeneric name

Erythromycin 0.5% eye ointment is a generic prescription medicine for ophthalmic use, made by 14 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store between 15°-25°C (59°-77°F).

Key facts

Active ingredient (INN)
Erythromycin
Brand
Sold under the generic name
Strength
0.5%
Dosage form
Eye ointment
Route
Ophthalmic
Packs
50 tubes, 1 tube, 3.5 g and 22 more
Manufacturers
NuCare Pharmaceuticals,IncAsclemedA-S Medication SolutionsArmas PharmaceuticalsBausch & LombProficient RxRedpharm DrugSentiss PharmaceuticalsCardinal HealthDirect_Rx
Origin register
US FDA, United States
Storage
Store between 15°-25°C (59°-77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
D10AF02 Erythromycin
HS code (indicative)
3004.20Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
29 July 1994
Identifiers
RxCUI 310149DailyMed set ID 9ac4dcd2-8cac-404d-b651-da74062d30ed, 50c8d6b3-4660-e829-e063-6294a90a919b, c49ad63b-c2fd-4535-bec0-6415c93cf847 +19NDC 61919-090, 68071-3992, 70518-0465 +19Application ANDA064067, ANDA064030, ANDA062447

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
50 tube in 1 carton / 1 g in 1 tube72485-670-31Armas Pharmaceuticals18 October 2023
1 tube in 1 carton / 3.5 g in 1 tube72485-670-35Armas Pharmaceuticals18 October 2023
50 tube in 1 box / 1 g in 1 tube24208-910-19Bausch & Lomb29 July 1994
1 tube in 1 carton / 3.5 g in 1 tube24208-910-55Bausch & Lomb29 July 1994
50 tube in 1 carton / 1 g in 1 tube70244-031-01Sentiss Pharmaceuticals1 April 2026
1 tube in 1 carton / 3.5 g in 1 tube70244-031-02Sentiss Pharmaceuticals1 April 2026
3.5 g in 1 box66267-975-35NuCare Pharmaceuticals,Inc28 July 2017
1 tube in 1 carton / 3.5 g in 1 tube68071-3992-2NuCare Pharmaceuticals,Inc1 May 2026
3.5 g in 1 box68071-4228-3NuCare Pharmaceuticals,Inc12 January 2018
3.5 g in 1 box68071-4803-3NuCare Pharmaceuticals,Inc14 March 2019
1 tube in 1 carton / 3.5 g in 1 tube76420-196-03Asclemed30 November 2021
1 tube in 1 carton / 3.5 g in 1 tube76420-212-30Asclemed8 March 2022
1 tube in 1 carton / 3.5 g in 1 tube76420-612-03Asclemed12 September 2023
1 tube in 1 carton / 3.5 g in 1 tube50090-1484-0A-S Medication Solutions2 December 2014
1 tube in 1 carton / 3.5 g in 1 tube50090-1958-0A-S Medication Solutions18 August 2015
1 tube in 1 carton / 3.5 g in 1 tube63187-267-35Proficient Rx1 January 2019
1 tube in 1 carton / 3.5 g in 1 tube63187-608-35Proficient Rx1 December 2018
1 tube in 1 carton / 3.5 g in 1 tube67296-2128-3Redpharm Drug18 October 2023
1 tube in 1 carton / 3.5 g in 1 tube67296-2343-4Redpharm Drug1 April 2026
10 tube in 1 bag / 1 g in 1 tube55154-7850-0Cardinal Health29 July 1994
3.5 g in 1 carton61919-090-35Direct Rx1 January 2015
1 tube in 1 carton / 3.5 g in 1 tube68788-9328-3Preferred Pharmaceuticals2 April 2015
1 tube in 1 carton / 3.5 g in 1 tube70518-0465-0Remedyrepack26 April 2017
1 tube in 1 carton / 3.5 g in 1 tube85766-248-55Sportpharm21 July 2026
1 tube in 1 carton / 3.5 g in 1 tube60760-670-35ST. Mary's Medical Park Pharmacy22 January 2025

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 25 June 1964Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Erythromycin

Clinical summary

Erythromycin is a macrolide antimicrobial indicated in the treatment of infections caused by susceptible strains of the designated organisms in the diseases listed below, among other approved uses. MedsAcross supplies Erythromycin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Erythromycin

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Erythromycin 0.5% eye ointment for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.